Renhuang Pharmaceuticals March 2010 Presentation

Post on 20-Jan-2015

618 views 2 download

Preview:

Click to see full reader
Report this document
SHARE

description

Renhuang Pharmaceuticals (PINK:RHGP) Renhuang Pharmaceuticals, Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its extensive distribution network of over 3,000 distributors and more than 70 sales centers across 24 provinces in China.

Transcript of Renhuang Pharmaceuticals March 2010 Presentation

EX-99.2 4 v176307_ex99-2.htm

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

1 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

2 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

3 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

4 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

5 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

6 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

7 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

8 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

9 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

10 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

11 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

12 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

13 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

14 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

15 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

16 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

17 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

18 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

19 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

20 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

21 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

22 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

23 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

24 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

25 of 26 3/5/2010 2:11 PM

v176307_ex99-2 -- Converted by SECPublisher 2.1.1.8, created by BCL ... http://sec.gov/Archives/edgar/data/926844/000114420410011412/v1763...

26 of 26 3/5/2010 2:11 PM

Top related

Pharmaceuticals and Medical Devices Safety Information No ... · “Pharmaceuticals and Medical Devices Safety Information No. 165” issued in March 2001. (2) Precautionary notifications
 Documents
India Symposium 2010 Pharmaceuticals
 Documents
Presentation - Ms. Karishma Phatarphekar - Pharmaceuticals and Manufacturing - 22 March 2014
 Documents
Modern Pharmaceuticals - May 2010
 Documents
Budget 2010 Snapshot Pharmaceuticals
 Documents
Global Regulatory Requirements for Enrollment of Women of ...martaonline.net/sites/martaonline.net/files/...ICH S9 March, 2010 Nonclinical Evaluation for Anticancer Pharmaceuticals
 Documents
Pharmaceuticals March 2014
 Documents
Managing COPD Nephron Pharmaceuticals Corporation Sponsored by Masters 14 August 2010.
 Documents
Addex Pharmaceuticals Investor Presentation June 2010.
 Documents
Pfizer Ireland Pharmaceuticals Ringaskiddy API Plant ... Ireland Pharmaceuticals Ringaskiddy API Plant Environmental Liabilities Risk Assessment 2010 Review Pfizer Ireland Pharmaceuticals\49340718
 Documents
PTO’s 2010 Obviousness Guidelines: Pharmaceuticals & Biotechnology
 Documents
Orchid Chemicals & Pharmaceuticals - Annual Report 2010-2011
 Documents
Addex Pharmaceuticals Corporate Presentation November 2010.
 Documents
Addex Pharmaceuticals Investor Presentation February 2010.
 Documents
TRACON PHARMACEUTICALS March 2018
 Documents
March 22, 2021 - BioCryst Pharmaceuticals
 Documents
Orchid Chemicals and Pharmaceuticals Ltd. Initiating Coverage March 2011
 Documents
Eagle Pharmaceuticals NASDAQ: EGRX Scott Tarriff, CEO David Riggs, CFO March 2015.
 Documents
Annual Report 2016 - Santen Pharmaceutical · March 31, 2016 Prescription Anti-Rheumatic Pharmaceuticals Over-the-Counter (OTC) Pharmaceuticals Medical Devices Others Business Domains
 Documents
Modern Pharmaceuticals - August 2010
 Documents

Copyright © 2022 FDOCUMENTS